Julius Fredens is one of the newest members of Singapore’s synbio community. After obtaining his PhD from University of Southern Denmark, he moved to the MRC Laboratory of Molecular Biology in Cambridge to work with Professor Jason Chin on genetic code compression.
To encourage reuse and reproducibility in the synthetic biology community, the National University of Singapore (NUS) Synthetic Biology for Clinical and Technological Innovation (SynCTI) has established SynbioResources, a digital collection of databases and tools related to synthetic biology.
One of the most unexpected food for microbes is carbon-rich gas. LanzaTech, a company founded in New Zealand and based in Illinois, USA, decided to challenge this conventional wisdom. By recycling carbon from...
A*STAR has established a new research institute to support Singapore’s sustainability goals. Known as the Institute of Sustainability for Chemicals, Energy and Environment (ISCE2, pronounced “I-S-C-E-squared”), the institute...
What if common baker’s yeast could be the answer to age-related diseases like dementia and Parkinson’s Disease? Researchers from NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) and Imperial College London...
Synthetic biology is the marriage between science and engineering to design and build biological parts and cutting-edge devices to help fuel bio-based economies. This motivation to accelerate innovation in synthetic biology between academia and industry resulted in the establishment of the Singapore Consortium for Synthetic Biology (SINERGY), hosted by NUS.
ENGAGE WITH US
28 Medical Drive, Centre for Life Sciences,
#02-07, Singapore 117456 [email protected]
+65 6601 6013